Finzony

Morepen Laboratories Limited

MOREPENLAB Healthcare
₹ 37.81
1.64%

Live Market Data

Market Cap₹ 2,072 Cr.
Current Price₹ 37.81
High / Low₹70.5 / 33.05
Stock P/E21.0
Book Value₹21.8
Dividend Yield0.53 %
ROCE0.0 %
ROE0.0 %

About Company

Morepen Laboratories Limited develops, manufactures, markets, and sells active pharmaceutical ingredients (APIs), branded and generic formulations, and home health products in India, the United States, and internationally. The company offers APIs for anti-histaminic, anti-asthmatic, anti-lipemic, anti-hypertensive, anti-diabetic, anti-coagulant, anti-ulcerative, and anti-depressant drugs; and home diagnostic products, such as air purifiers, sphygmomanometers, blood glucose test strips, blood pressure monitors, breathe free vaporizers, stethoscopes, digital thermometers, blood glucose monitors, nebulizers, heat belts, and pulse oximeters. It also provides OTC and healthcare products, including fever X for fever; Pain X for pain; Fiber-X for constipation; sat isabgol; Acidity X for acidity; Burnol, a first degree/minor burns cream; and formulations for nutrition and probiotics, gastroenterology, antibiotics, gynecology, anti-allergic, and central nervous system, as well as cardiology, diabetology, and nutraceuticals. The company offers over the counter products under the Dr. Morepen brand name. Morepen Laboratories Limited was incorporated in 1984 and is based in Gurugram, India.

Industry Segment

Drug Manufacturers - Specialty & Generic

Price Chart

Loading Chart...

Technical Analysis

Technical Outlook

Short TermBearish
Mid TermBearish
Long TermNeutral
Resistance₹67.86000061035156
Support₹33.68000030517578

Valuation Check

Fair Value Assessment
Fair Value

Research Reports

No recent reports available.

Peer Comparison

Related Sector
CompanyPriceP/EM.Cap (Cr)ROE %
MARKSANS PHARMA LIMITED
MARKSANS
₹168.1521.157,620-
HFCL LIMITED
HFCL
₹71.72199.2210,975-
TRIDENT LIMITED
TRIDENT
₹24.1230.1512,304-
MANALI PETROCHEMICALS LT
MANALIPETC
₹42.866.60740-
LAURUS LABS LIMITED
LAURUSLABS
₹1,042.966.6856,315-

Quarterly Results

ParticularsDec 25Sept 25Jun 25Mar 25Dec 24
Total Revenue (Cr)484.16411.58425.24458.01452.78
Net Income (Cr)27.5140.8710.7520.3226.69
EPS (₹)0.50.750.200.49

Annual Profit & Loss

Particulars2025202420232022
Total Revenue (Cr)1,803.731,682.131,413.951,541.57
Operating Exp (Cr)472.97473.46391.98371.6
Net Income (Cr)118.0296.1638.68101.68
EPS (₹)2.21.880.772.26

Balance Sheet

ParticularsDec 25Sept 25Jun 25Mar 25Dec 24
Total Assets (Cr)-1,736.14-1,778.1-
Total Liabilities (Cr)-539.19-591.14-
Total Equity (Cr)-1,196.23-1,156.23-

Key Ratios Fundamentals

Valuation

P/E Ratio (TTM)
21.01
Forward P/E
-
PEG Ratio
-
Price / Book
1.74
EV / EBITDA
21.44

Profitability

ROE
-
ROA
-
Profit Margin
5.57%
Operating Margin
7.42%

Liquidity & Debt

Current Ratio
-
Quick Ratio
-
Debt / Equity
13.24
Total Cash (Cr)
80.87

Price Statistics

Beta
0.78
52W High
70.50
52W Low
33.05
Dividend Yield
0.53%

Pattern Unavailable

Detailed shareholding breakdown is not currently provided by the exchange.